Wang Hong, D'Ambrosio Martin A, Ren YiLin, Monu Sumit R, Leung Pablo, Kutskill Kristopher, Garvin Jeffrey L, Janic Branislava, Peterson Edward L, Carretero Oscar A
Division of Hypertension and Vascular Research, Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan;
Division of Hypertension and Vascular Research, Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan; Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio; and.
Am J Physiol Renal Physiol. 2015 May 1;308(9):F1026-31. doi: 10.1152/ajprenal.00605.2014. Epub 2015 Feb 25.
Afferent (Af-Art) and efferent arterioles resistance regulate glomerular capillary pressure. The nephron regulates Af-Art resistance via: 1) vasoconstrictor tubuloglomerular feedback (TGF), initiated in the macula densa via Na-K-2Cl cotransporters (NKCC2) and 2) vasodilator connecting tubuloglomerular feedback (CTGF), initiated in connecting tubules via epithelial Na channels (ENaC). Furosemide inhibits NKCC2 and TGF. Benzamil inhibits ENaC and CTGF. In vitro, CTGF dilates preconstricted Af-Arts. In vivo, benzamil decreases stop-flow pressure (PSF), suggesting that CTGF antagonizes TGF; however, even when TGF is blocked, CTGF does not increase PSF, suggesting there is another mechanism antagonizing CTGF. We hypothesize that in addition to NKCC2, activation of Na/H exchanger (NHE) antagonizes CTGF, and when both are blocked CTGF dilates Af-Arts and this effect is blocked by a CTGF inhibitor benzamil. Using micropuncture, we studied the effects of transport inhibitors on TGF responses by measuring PSF while increasing nephron perfusion from 0 to 40 nl/min. Control TGF response (-7.9 ± 0.2 mmHg) was blocked by furosemide (-0.4 ± 0.2 mmHg; P < 0.001). Benzamil restored TGF in the presence of furosemide (furosemide: -0.2 ± 0.1 vs. furosemide+benzamil: -4.3 ± 0.3 mmHg; P < 0.001). With furosemide and NHE inhibitor, dimethylamiloride (DMA), increase in tubular flow increased PSF (furosemide+DMA: 2.7 ± 0.5 mmHg, n = 6), and benzamil blocked this (furosemide+DMA+benzamil: -1.1 ± 0.2 mmHg; P < 0.01, n = 6). We conclude that NHE in the nephron decreases PSF (Af-Art constriction) when NKCC2 and ENaC are inhibited, suggesting that in the absence of NKCC2, NHE causes a TGF response and that CTGF dilates the Af-Art when TGF is blocked with NKCC2 and NHE inhibitors.
入球(Af-Art)和出球小动脉阻力调节肾小球毛细血管压力。肾单位通过以下方式调节Af-Art阻力:1)血管收缩性的管球反馈(TGF),由致密斑中的钠-钾-2氯共转运体(NKCC2)启动;2)血管舒张性的连接管球反馈(CTGF),由连接小管中的上皮钠通道(ENaC)启动。呋塞米抑制NKCC2和TGF。苯扎明抑制ENaC和CTGF。在体外,CTGF使预先收缩的Af-Arts舒张。在体内,苯扎明降低停流压力(PSF),提示CTGF拮抗TGF;然而,即使TGF被阻断,CTGF也不会增加PSF,提示存在另一种机制拮抗CTGF。我们推测,除了NKCC2外,钠/氢交换体(NHE)的激活也拮抗CTGF,当两者都被阻断时,CTGF使Af-Arts舒张,且这种作用被CTGF抑制剂苯扎明阻断。通过微穿刺技术,我们在将肾单位灌注率从0增加到40 nl/min的同时测量PSF,研究了转运抑制剂对TGF反应的影响。对照TGF反应(-7.9±0.2 mmHg)被呋塞米阻断(-0.4±0.2 mmHg;P<0.001)。在存在呋塞米的情况下,苯扎明恢复了TGF(呋塞米:-0.2±0.1 vs. 呋塞米+苯扎明:-4.3±0.3 mmHg;P<0.001)。使用呋塞米和NHE抑制剂二甲基氨氯吡脒(DMA)时,肾小管流量增加使PSF升高(呋塞米+DMA:2.7±0.5 mmHg,n = 6),而苯扎明阻断了这一作用(呋塞米+DMA+苯扎明:-1.1±0.2 mmHg;P<0.01,n = 6)。我们得出结论,当NKCC2和ENaC被抑制时,肾单位中的NHE降低PSF(Af-Art收缩),提示在没有NKCC2的情况下,NHE引发TGF反应,并且当TGF被NKCC2和NHE抑制剂阻断时,CTGF使Af-Art舒张。